Barclays’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $592K | Sell |
64,795
-27,728
| -30% | -$233K | ﹤0.01% | 3086 |
|
|
2025
Q4 | $688K | Buy |
92,523
+26,547
| +40% | +$191K | ﹤0.01% | 3676 |
|
|
2025
Q3 | $441K | Sell |
65,976
-22,132
| -25% | -$154K | ﹤0.01% | 3890 |
|
|
2025
Q2 | $583K | Buy |
88,108
+41,032
| +87% | +$291K | ﹤0.01% | 3679 |
|
|
2025
Q1 | $431K | Sell |
47,076
-19,261
| -29% | -$192K | ﹤0.01% | 3617 |
|
|
2024
Q4 | $697K | Buy |
66,337
+15,683
| +31% | +$185K | ﹤0.01% | 3623 |
|
|
2024
Q3 | $605K | Buy |
50,654
+9,854
| +24% | +$85.2K | ﹤0.01% | 3657 |
|
|
2024
Q2 | $235K | Buy |
40,800
+6,498
| +19% | +$35.6K | ﹤0.01% | 3495 |
|
|
2024
Q1 | $178K | Sell |
34,302
-25,290
| -42% | -$124K | ﹤0.01% | 4179 |
|
|
2023
Q4 | $314K | Buy |
59,592
+23,522
| +65% | +$93.1K | ﹤0.01% | 4171 |
|
|
2023
Q3 | $119K | Buy |
+36,070
| New | +$127K | ﹤0.01% | 3533 |
|
|
2023
Q2 | – | Sell |
-18,524
| Closed | -$19.8K | – | 4590 |
|
|
2023
Q1 | $19.8K | Buy |
18,524
+9,945
| +116% | +$19K | ﹤0.01% | 4661 |
|
|
2022
Q4 | $22.4K | Buy |
8,579
+7,239
| +540% | +$31.6K | ﹤0.01% | 4783 |
|
|
2022
Q3 | $9K | Sell |
1,340
-246
| -16% | -$1.93K | ﹤0.01% | 4344 |
|
|
2022
Q2 | $11K | Sell |
1,586
-2,967
| -65% | -$30.3K | ﹤0.01% | 4591 |
|
|
2022
Q1 | $65K | Sell |
4,553
-29,475
| -87% | -$395K | ﹤0.01% | 3994 |
|
|
2021
Q4 | $493K | Buy |
34,028
+27,465
| +418% | +$390K | ﹤0.01% | 3210 |
|
|
2021
Q3 | $93K | Buy |
6,563
+5,510
| +523% | +$84.8K | ﹤0.01% | 3932 |
|
|
2021
Q2 | $19K | Sell |
1,053
-6,509
| -86% | -$105K | ﹤0.01% | 4504 |
|
|
2021
Q1 | $116K | Buy |
+7,562
| New | +$108K | ﹤0.01% | 3938 |
|
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
